Cooley Attys Savor Amgen-Horizon Close After FTC Battle
Upon the close of Amgen's $28 billion acquisition of Ireland's Horizon Therapeutics on Friday, following a tense battle with the Federal Trade Commission, Cooley LLP partners representing Horizon said the end...To view the full article, register now.
Already a subscriber? Click here to view full article